IS6098A - Ósantant til meðhöndlunar á skaptruflunum - Google Patents

Ósantant til meðhöndlunar á skaptruflunum

Info

Publication number
IS6098A
IS6098A IS6098A IS6098A IS6098A IS 6098 A IS6098 A IS 6098A IS 6098 A IS6098 A IS 6098A IS 6098 A IS6098 A IS 6098A IS 6098 A IS6098 A IS 6098A
Authority
IS
Iceland
Prior art keywords
incantant
treatment
mood disorders
mood
disorders
Prior art date
Application number
IS6098A
Other languages
English (en)
Inventor
Emonds-Alt Xavier
Soubrie Philippe
Steinberg Regis
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS6098A publication Critical patent/IS6098A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
IS6098A 1999-04-13 2001-09-28 Ósantant til meðhöndlunar á skaptruflunum IS6098A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
PCT/FR2000/000924 WO2000061125A2 (fr) 1999-04-13 2000-04-11 L'osanetant dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
IS6098A true IS6098A (is) 2001-09-28

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6098A IS6098A (is) 1999-04-13 2001-09-28 Ósantant til meðhöndlunar á skaptruflunum

Country Status (24)

Country Link
US (1) US6420388B1 (is)
EP (1) EP1175215A2 (is)
JP (1) JP2002541190A (is)
KR (1) KR20010105418A (is)
CN (1) CN1354662A (is)
AR (1) AR023452A1 (is)
AU (1) AU3971600A (is)
BR (1) BR0009704A (is)
CA (1) CA2369638A1 (is)
CZ (1) CZ20013645A3 (is)
EE (1) EE200100527A (is)
FR (1) FR2792199B3 (is)
HR (1) HRP20010741A2 (is)
HU (1) HUP0200655A3 (is)
ID (1) ID30458A (is)
IS (1) IS6098A (is)
MX (1) MXPA01010340A (is)
NO (1) NO20014953L (is)
PE (1) PE20010032A1 (is)
PL (1) PL351554A1 (is)
SK (1) SK14552001A3 (is)
TR (1) TR200102930T2 (is)
WO (1) WO2000061125A2 (is)
ZA (1) ZA200108289B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
WO2005061544A2 (en) * 2003-12-22 2005-07-07 Glaxo Group Limited Nogo-a neutralising immunoglobulins for treatment of neurological diseases
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、ｎｋ３アンタゴニストの使用
EP1867717A4 (en) * 2005-03-15 2008-08-20 Sumitomo Chemical Co METHOD FOR REDUCE SYMPTOM CAUSED BY MUTUAL DISORDER
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EP1175215A2 (fr) 2002-01-30
PL351554A1 (en) 2003-05-05
TR200102930T2 (tr) 2002-04-22
CZ20013645A3 (cs) 2002-01-16
NO20014953L (no) 2001-12-11
NO20014953D0 (no) 2001-10-11
US6420388B1 (en) 2002-07-16
AU3971600A (en) 2000-11-14
FR2792199A1 (fr) 2000-10-20
EE200100527A (et) 2002-12-16
ZA200108289B (en) 2002-12-24
SK14552001A3 (sk) 2002-02-05
AR023452A1 (es) 2002-09-04
CA2369638A1 (en) 2000-10-19
PE20010032A1 (es) 2001-04-11
HUP0200655A2 (hu) 2002-07-29
JP2002541190A (ja) 2002-12-03
KR20010105418A (ko) 2001-11-28
FR2792199B3 (fr) 2001-05-18
BR0009704A (pt) 2002-01-08
CN1354662A (zh) 2002-06-19
HUP0200655A3 (en) 2002-11-28
MXPA01010340A (es) 2002-05-06
ID30458A (id) 2001-12-06
WO2000061125A3 (fr) 2001-04-19
WO2000061125A2 (fr) 2000-10-19
HRP20010741A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
IS5085A (is) Nefholssamsetningar til meðhöndlunar á kynferðistruflunum
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
IS7941A (is) Bensasepínafleiður til að meðhöndla taugasjúkdóma
IS6303A (is) Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
IS6137A (is) Meðhöndlun á hugsýkistruflunum
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
IS3004B (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
DK1200114T3 (da) PPAR delta inhibitorer til behandling af kardiovaskulære sygdomme